Pulmonary circulation : diseases and their treatment.
Saved in:
| Edition: | 2nd ed. |
|---|---|
| Imprint: | London : Arnold, 2004. |
| Description: | xxiii, 614 p. ; 28 cm. |
| Language: | English |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/5545670 |
Table of Contents:
- Contributors
- Foreword
- Preface
- Abbreviations
- A note on references
- Part 1. The Structure and Function of the Normal Pulmonary Circulation
- 1. Pulmonary vascular function
- 2. Functional anatomy of the pulmonary microcirculation
- Part 2. Pathophysiology and Pathology of Pulmonary Vascular Disease
- 3. Pathology of pulmonary vascular disease
- 4. Hypoxic pulmonary vasoconstriction and hypertension
- 5. Pulmonary vascular remodeling
- 6. The genetics of pulmonary hypertension
- Part 3. The Diagnosis of Pulmonary Hypertension
- 7. Clinical features
- 8. Echocardiography
- 9. Imaging
- 10. Cardiac catheterization of patients with pulmonary hypertension
- 11. An integrated approach to the diagnosis of pulmonary hypertension
- Part 4. Disorders Associated with Pulmonary Hypertension: Pathobiology, Diagnosis and Treatment
- 12. Classification and clinical features of PHT
- 13. Pulmonary arterial hypertension
- 13A. Pathobiology of pulmonary arterial hypertension
- 13B. Primary pulmonary hypertension: pathophysiological and clinical aspects
- 13C. Familial primary pulmonary hypertension
- 13D. Pulmonary hypertension associated with connective tissue disease
- 13E. Pulmonary hypertension related to appetite suppressants
- 13F. Pulmonary hypertension associated with portal hypertension
- 13G. Pulmonary hypertension related to HIV infection
- 13H. Pulmonary hypertension in association with congenital systemic-to-pulmonary shunts
- 13I. Pulmonary vasculitis
- 13J. Pulmonary hypertension in sickle cell disease and thalassemia
- 13K. Conventional medical therapies
- 13L. Intravenous prostacyclin for pulmonary arterial hypertension
- 13M. Inhaled iloprost
- 13N. Oral and subcutaneous prostacyclin analogs
- 13O. Inhaled nitric oxide
- 13P. Endothelin receptor antagonists
- 13Q. Novel medical approaches--growth inhibitors
- 13R. Lung transplantation
- 13S. Atrial septostomy
- 13T. An integrated approach to the treatment of pulmonary arterial hypertension
- 14. Pulmonary venous hypertension
- 14A. Diagnosis and treatment of left heart disease
- 14B. Pulmonary veno-occlusive disease
- 14C. Pulmonary capillary hemangiomatosis
- 15. Pulmonary hypertension associated with disorders of the respiratory system and/or hypoxemia
- 15A. Pulmonary hypertension due to chronic hypoxic lung disease
- 15B. Pulmonary circulation in obstructive sleep apnea
- 15C. An integrated approach to the treatment of pulmonary hypertension due to hypoxic lung disease
- Part 5. Pulmonary Thromboembolism and Pulmonary Vascular Tumors
- 16. Acute pulmonary thromboembolism
- 16A. Diagnosis
- 16B. Treatment
- 17. Chronic thromboembolic pulmonary hypertension
- 18. Pulmonary vascular tumors
- Part 6. Pulmonary Hypertension in Pediatrics
- 19. Primary pulmonary hypertension in children
- 20. Persistent pulmonary hypertension of the newborn: strategies in clinical management
- Part 7. Pulmonary Circulation in Critical Care
- 21. Effects of mechanical ventilation on the pulmonary circulation
- 22. Effects of lung injury on the pulmonary circulation
- 23. Pharmacological management of the pulmonary circulation in critically ill patients
- Part 8. Pulmonary Circulation in Special Environments
- 24. High altitude, high-altitude pulmonary edema and the pulmonary circulation
- 25. The pulmonary circulation in the underwater environment
- 26. The fetal lung circulation
- Part 9. Disorders Causing Intrapulmonary Shunt
- 27. Hepatopulmonary syndrome
- 28. Pulmonary arteriovenous malformations
- Index
